BPG is committed to discovery and dissemination of knowledge
Articles Published Processes
6/11/2021 9:22:19 AM | Browse: 310 | Download: 390
Publication Name World Journal of Clinical Cases
Manuscript ID 63794
Country/Territory Portugal
Received
2021-02-08 11:29
Peer-Review Started
2021-02-08 11:33
To Make the First Decision
Return for Revision
2021-04-25 04:46
Revised
2021-05-04 15:45
Second Decision
2021-05-08 06:28
Accepted by Journal Editor-in-Chief
Accepted by Company Editor-in-Chief
2021-05-08 08:49
Articles in Press
2021-05-08 08:49
Publication Fee Transferred
Edit the Manuscript by Language Editor
2021-05-13 19:27
Typeset the Manuscript
2021-05-29 03:52
Publish the Manuscript Online
2021-06-11 09:22
ISSN 2307-8960 (online)
Open Access This article is an open-access article that was selected by an in-house editor and fully peer-reviewed by external reviewers. It is distributed in accordance with the Creative Commons Attribution NonCommercial (CC BY-NC 4.0) license, which permits others to distribute, remix, adapt, build upon this work non-commercially, and license their derivative works on different terms, provided the original work is properly cited and the use is non-commercial. See: http://creativecommons.org/Licenses/by-nc/4.0/
Copyright © The Author(s) 2021. Published by Baishideng Publishing Group Inc. All rights reserved.
Article Reprints For details, please visit: http://www.wjgnet.com/bpg/gerinfo/247
Permissions For details, please visit: http://www.wjgnet.com/bpg/gerinfo/207
Publisher Baishideng Publishing Group Inc, 7041 Koll Center Parkway, Suite 160, Pleasanton, CA 94566, USA
Website http://www.wjgnet.com
Category Oncology
Manuscript Type Case Report
Article Title Long-term response to avelumab and management of oligoprogression in Merkel cell carcinoma: A case report
Manuscript Source Unsolicited Manuscript
All Author List Inês Leão, Joana Marinho and Telma Costa
ORCID
Author(s) ORCID Number
Inês Leão http://orcid.org/0000-0002-6586-4980
Joana Marinho http://orcid.org/0000-0003-3665-4666
Telma Costa http://orcid.org/0000-0002-9625-1124
Funding Agency and Grant Number
Corresponding Author Telma Costa, MD, Doctor, Department of Oncology, Centro Hospitalar Vila Nova de Gaia/Espinho, Rua Conceição Fernandes, Vila Nova de Gaia 4434-502, Portugal. telma.r.c.costa@gmail.com
Key Words Merkel cell carcinoma; Unresectable tumor; Avelumab; Oligoprogression; Surgery; Chemotherapy; Case report
Core Tip This report highlights the efficacy and long-term response of avelumab, on the management of a chemotherapy resistant advanced Merkel cell carcinoma (MCC). It shows also a successful approach to oligoprogression with local radical treatment, surgery and radiotherapy, while maintaining systemic therapy with avelumab. The results support the effectiveness of this strategy for the management of unresectable MCC.
Publish Date 2021-06-11 09:22
Citation Leão I, Marinho J, Costa T. Long-term response to avelumab and management of oligoprogression in Merkel cell carcinoma: A case report. World J Clin Cases 2021; 9(18): 4829-4836
URL https://www.wjgnet.com/2307-8960/full/v9/i18/4829.htm
DOI https://dx.doi.org/10.12998/wjcc.v9.i18.4829
Full Article (PDF) WJCC-9-4829.pdf
Full Article (Word) WJCC-9-4829.docx
CARE Checklist–2016 63794-CARE-Checklist–2016-revision.pdf
Manuscript File 63794-Review-FilipodiaCL.docx
Answering Reviewers 63794-Answering reviewers.pdf
Audio Core Tip 63794-Audio core tip.ogg
Conflict-of-Interest Disclosure Form 63794-Conflict-of-interest statement.pdf
Copyright License Agreement 63794-Copyright license agreement.pdf
Signed Informed Consent Form(s) or Document(s) 63794-Informed consent statement.pdf
Non-Native Speakers of English Editing Certificate 63794-Language certificate.pdf
Peer-review Report 63794-Peer-review(s).pdf
Scientific Misconduct Check 63794-Bing-Fan JR-2.png
Scientific Misconduct Check 63794-Bing-Ma YJ-1.jpg
Scientific Misconduct Check 63794-Scientific misconduct check.pdf
Scientific Editor Work List 63794-Scientific editor work list.pdf